Gene Sequencing Experiment: Principles, Methods, Standards, and Applications

A gene sequencing experiment is a laboratory procedure that determines the precise order of nucleotides within a DNA or RNA molecule, providing foundational data for clinical diagnostics, biotechnology research, food safety, and genetic breeding. This technical article explains the experimental workflow, sample requirements, testing items, sequencing methodologies, quality standards, and typical applications of gene sequence determination. Whether you are a researcher, quality engineer, or laboratory manager, this guide will help you understand how accredited third-party laboratories perform gene sequencing under internationally recognized quality systems.

Technical Overview

A gene sequencing experiment is designed to decode the exact sequence of adenine (A), thymine (T), cytosine (C), and guanine (G) bases in a nucleic acid molecule. Since the development of the chain-termination method in 1977, sequencing technology has advanced through three major generations: first-generation capillary electrophoresis sequencing, second-generation massively parallel next-generation sequencing (NGS), and third-generation single-molecule long-read sequencing.

A typical gene sequencing experiment follows a standardized workflow: sample collection and transport, genomic DNA or RNA extraction, nucleic acid quality and quantity assessment, library preparation, sequencing reaction on a suitable platform, bioinformatic analysis, and result interpretation. Each stage is governed by documented procedures to guarantee traceability, reproducibility, and data integrity.

Professional sequencing services are generally performed in accredited third-party laboratories operating under quality management frameworks such as ISO/IEC 17025 for testing laboratories or ISO 15189 for medical laboratories. These systems cover personnel qualification, instrument calibration, environmental control, reference material usage, and comprehensive documentation of every experimental step.

Testing Samples

Blood and Body Fluid Samples

Peripheral blood collected in EDTA anticoagulant tubes is the most common sample type for human genomic sequencing. Heparinized blood is generally avoided because heparin inhibits polymerase activity during amplification. Typical requirements include 1 to 5 mL of whole blood, transported at 2 to 8 °C and processed within 48 to 72 hours to ensure DNA integrity.

Tissue Samples

Fresh-frozen tissue is preferred for high-quality library construction, while formalin-fixed paraffin-embedded (FFPE) tissue is widely accepted for retrospective clinical studies. FFPE samples often yield fragmented DNA, so experimental protocols must include fragmentation assessment and short-fragment library strategies to achieve reliable results.

Swab and Cell Samples

Buccal swabs, cervical swabs, and cultured cell pellets are convenient non-invasive sources of genomic DNA. Samples should be air-dried before packaging and shipped at ambient temperature with desiccant to prevent microbial growth and nucleic acid degradation.

Microbial Samples

Bacterial isolates, fungal cultures, and viral concentrates can be sequenced for identification, typing, and resistance-gene detection. Pure cultures are strongly recommended to avoid mixed chromatograms or ambiguous reads during data analysis.

Plant and Animal Samples

Young leaves, seeds, blood, muscle tissue, and hair follicles from plants and animals are used for genome sequencing, marker-assisted breeding, and species authentication. Fresh plant material should be frozen in liquid nitrogen immediately after collection to inactivate endogenous nucleases.

Environmental and Food Samples

Soil, water, fermented products, and processed foods can be analyzed through metagenomic or amplicon sequencing to profile microbial communities, detect pathogens, and verify ingredient authenticity. These complex matrices require specialized extraction kits capable of removing humic acids, lipids, and other PCR inhibitors.

Testing Items

Gene sequencing experiments cover a broad range of testing items, each tailored to a specific analytical objective:

• Whole genome sequencing (WGS): complete determination of an organism's entire genetic complement.
• Whole exome sequencing (WES): targeted capture and sequencing of all protein-coding regions.
• Targeted gene panel sequencing: focused analysis of disease-associated or trait-associated genes.
• De novo sequencing: assembly of previously uncharacterized genomes without a reference sequence.
• Transcriptome sequencing (RNA-seq): quantification and characterization of gene expression profiles.
• 16S rRNA, 18S rRNA, and ITS amplicon sequencing: microbial community structure and diversity analysis.
• Metagenomic sequencing: comprehensive profiling of all genetic material in complex samples.
• Mitochondrial genome sequencing: matrilineal lineage tracing and mitochondrial disease studies.
• Sanger sequencing of specific fragments: sequence confirmation, plasmid verification, and mutation validation.
• Genotyping and SNP detection: identification of single nucleotide polymorphisms associated with traits or diseases.

Testing Methods

First-Generation Sanger Sequencing

The chain-termination method uses fluorescently labeled dideoxynucleotides to terminate DNA strand elongation at specific bases. Capillary electrophoresis separates the terminated fragments by length, and a detector records the fluorescence signal to reconstruct the sequence. Sanger sequencing delivers read lengths of approximately 700 to 1000 bases with accuracy above 99.9 percent, making it the gold standard for confirmatory sequencing of short fragments.

Second-Generation Next-Generation Sequencing

NGS platforms perform millions to billions of sequencing reactions in parallel. Sequencing-by-synthesis chemistry detects fluorescent signals as reversible terminators are incorporated into growing DNA strands on a flow cell. Semiconductor-based platforms detect hydrogen ions released during nucleotide incorporation. NGS delivers high throughput and low per-base cost, with common quality benchmarks including a Q30 base quality score above 80 to 90 percent and uniform coverage across target regions.

Third-Generation Single-Molecule Sequencing

Single-molecule real-time (SMRT) sequencing monitors fluorescence from individual polymerase molecules in real time, producing reads of 10 to 25 kilobases or longer. Nanopore sequencing measures ionic current changes as DNA strands pass through engineered protein nanopores, enabling ultra-long reads and direct detection of base modifications. Long-read technologies excel at resolving structural variants, repetitive regions, and full-length transcript isoforms.

Bioinformatic Analysis

Raw sequencing data undergo base calling, adapter and quality trimming, alignment to a reference genome, variant calling, and functional annotation. Standard pipelines incorporate duplicate removal, base quality score recalibration, and statistical filtering to reduce false positives. Final reports document sequencing depth, coverage statistics, mapping rate, and variant classification according to established interpretation guidelines.

Quality Control Measures

Throughout the experiment, quality checkpoints include nucleic acid concentration measured by fluorometric assay, purity assessed by spectrophotometric absorbance ratios, integrity evaluated by gel electrophoresis or microfluidic electrophoresis, and library size distribution verified before sequencing. Negative controls, positive reference materials, and replicate analyses are applied where appropriate to monitor contamination and reproducibility.

Applications

Gene sequencing experiments serve diverse industries and scientific disciplines:

• Clinical diagnostics: identification of hereditary disease mutations, carrier screening, and prenatal genetic testing.
• Oncology: tumor mutation profiling, companion diagnostic development, and minimal residual disease monitoring.
• Infectious disease: pathogen identification, outbreak tracing, and antimicrobial resistance gene detection.
• Pharmacogenomics: prediction of individual drug response based on metabolic enzyme and transporter genotypes.
• Forensic science: human identity verification, kinship analysis, and biological evidence attribution.
• Agriculture and breeding: molecular marker development, trait-gene mapping, and seed purity certification.
• Food safety and authenticity: species identification, GMO detection, and adulteration screening.
• Environmental and ecological research: biodiversity assessment, microbial ecology, and environmental monitoring.
• Biotechnology and drug development: strain engineering, enzyme discovery, and biopharmaceutical characterization.

FAQ

How much sample is required for a gene sequencing experiment?

Requirements depend on the sequencing strategy. Sanger sequencing typically needs 10 to 50 ng of PCR product or plasmid DNA, while whole genome sequencing generally requires 500 ng to 1 microgram of high-quality genomic DNA with appropriate purity ratios. Accredited third-party laboratories provide detailed submission guidelines for each project type.

What is the difference between Sanger sequencing and next-generation sequencing?

Sanger sequencing reads a single DNA fragment at a time with long, highly accurate reads, making it ideal for confirming short targeted regions. NGS sequences millions of fragments simultaneously, delivering far greater throughput and lower cost per base, which suits large-scale genomic studies and complex sample analysis.

How long does a gene sequencing experiment take?

Turnaround time varies by project scope. A single Sanger fragment can be completed within one to two working days, targeted panels typically require one to two weeks, and whole genome projects with full bioinformatic analysis may take two to six weeks depending on sample complexity and data volume.

How is sequencing accuracy ensured?

Accuracy is safeguarded through validated extraction and library protocols, calibrated instruments, inclusion of control samples, sequencing depth requirements, and standardized bioinformatic pipelines. Critical variants identified by NGS are frequently confirmed by independent Sanger sequencing.

Is genetic data kept confidential?

Reputable laboratories implement strict data security policies, including coded sample identification, access-controlled servers, encrypted data transfer, and contractual confidentiality agreements, ensuring that client genetic information remains protected throughout and after the project.

Which standards apply to gene sequencing laboratories?

Testing laboratories commonly operate under ISO/IEC 17025 for general testing competence, ISO 15189 for medical laboratory requirements, and applicable national standards such as GB/T series technical specifications for sequencing data processing. Compliance with these frameworks demonstrates technical validity and internationally comparable data quality.